Expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in human breast carcinoma cells and tissues

Wings T.Y. Loo, Louis W.C. Chow, Takashi Suzuki, Katsuhiko Ono, Takanori Ishida, Hisashi Hirakawa, Noriaki Ohuchi, Hironobu Sasano

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Background: The therapeutic effects of oral capecitabine are proposed to be determined by the equilibrium of two intratumoral metabolizing enzymes, namely thymidine Phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD). The present study aims to evaluate this hypothesis by in vivo experiments and immuno-histochemical analysis in 31 cases of human breast carcinoma. Materials and Methods: The effects of capecitabine on two breast carcinoma cell lines were evaluated by the status of both cell proliferation and apoptosis and mRNA levels of TP and DPD were also determined. TP and DPD status was determined by immunohistochemistry in 31 cases of breast carcinoma tissues and the results were compared with their clinicopathological parameters. Results: The therapeutic efficacy of capecitabine in two cell lines was not related to the levels of TP and DPD mRNA expression. No statistically significant association was detected between the status of these enzymes and the clinicopathological factors. Conclusion: In vitro study demonstrated that capecitabine was effective against the BT-483 and MB-MDA-231 breast carcinoma cell lines used but the significance of the status of intratumoral TP and DPD in determining its therapeutic efficacy needs further studies.

Original languageEnglish
Pages (from-to)2525-2530
Number of pages6
JournalAnticancer research
Volume29
Issue number7
Publication statusPublished - 2009 Jul

Keywords

  • Apoptosis
  • Capecitabine
  • Cell proliferation
  • Dihydropyrimidine dehydrogenase
  • Thymidine phosphorylase

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in human breast carcinoma cells and tissues'. Together they form a unique fingerprint.

Cite this